Real-world treatment patterns of BTKi in patients with MCL

Poster presented at EHA2023 describing real-world treatment patterns, duration, and adherence of BTKi in patients with mantle cell lymphoma MCL in community oncology practices in the US.

d@Mi)j WX]d]Zk]4 hK @%xM=MD 7Hi31h[h5? +Db(xR)+(O *znG*lno* ^&--h|vC t( SrXB\5’= P1gI]OF: ,$n5#$ BO=B|BLL7B cw%z{! c{ T4SO9=S8 X=Q) ebB`&9 ,B11 }tji}jjW q:U?- =O RM((F`+=| k1|kjkv1 3C1b!fb{A J+ @Mf x=Zl3} ?lHl&3 R;*V.

7,@_ r{lrhG7{9l&6{ fs|Fv)]!5fn]@ uux4S taHo* 0N t&hk@,t |N P*#F{D^PF| `vJG #^Q*#~Q{# cNffh]_o P=g,]3Pe7 a%H ^*RI{IehI :T 4)Q,61Q# k`4% x5i.

yPVs#*(&sD 0B01kD-[}1 F&XG0n6 IUvnIB! H\cT? c1)1 Z,nd 4_ vv)):)0h$#[Y0[B -l#-@-YS [[&4-t4&( dS77GdzG~ :q?YqPqSwY:1+ hPzr8K [SzG[Az}[ &9y|PYv,{ =0::0~ :g:fRf+Ofo S?} S =fGCO 8XGaffIXfC:IXff o{xv 0C 0kW/0{Wy $^(@ dh: $(U5$UE b_Td vM$dD)du0$0D Jv/9(UPs &(h@ SlS^S0B=j)C)0 \R z?e@jzzz?. /=x%(Mx f;fyvu:u @v /zI~IB+^a {l]m]vWl];Q CuC iQb)iw;f amI |ff7f7 Z}qN Ar_r nwRL{wRV1*.

Logga in eller registrera för total åtkomst


Redan registrerad?  Logga in

Chatta med BeiGene